Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cortesi

Showing results (151-160 of 181) with videos related to

Pageof 19
Sort By:
Cancer Medicine|February 12, 2020
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year resultsLaura Cortesi, Bruna Baldassarri, Stefano Ferretti, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2024
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patientsGiulia Orsi, Catia Carconi, Paola Ghiorzo, et al.
NPJ Breast Cancer|December 13, 2025
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancerEmma Zattarin, Antonio Marra, Antonella Palazzo, et al.
Methods and Protocols|August 28, 2024
Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years of Operation: An Observational Study ProtocolStefano Ferretti, Priscilla Sassoli de Bianchi, Debora Canuti, et al.
Frontiers in Oncology|December 20, 2018
Contribution of <i>MUTYH</i> Variants to Male Breast Cancer Risk: Results From a Multicenter Study in ItalyPiera Rizzolo, Valentina Silvestri, Agostino Bucalo, et al.
International Journal of Molecular Sciences|July 24, 2021
Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory RegionsChiara Guglielmi, Rosa Scarpitta, Gaetana Gambino, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Cancer|September 21, 2016
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility geneValentina Silvestri, Veronica Zelli, Virginia Valentini, et al.
Cancer Treatment Reviews|August 29, 2024
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical reviewAlberto Zambelli, Laura Cortesi, Mariangela Gaudio, et al.
Radiology|January 25, 2007
Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim resultsFrancesco Sardanelli, Franca Podo, Giuliano D'Agnolo, et al.
Pageof 19

Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
Cancer Medicine|February 12, 2020
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year resultsLaura Cortesi, Bruna Baldassarri, Stefano Ferretti, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2024
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patientsGiulia Orsi, Catia Carconi, Paola Ghiorzo, et al.
NPJ Breast Cancer|December 13, 2025
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancerEmma Zattarin, Antonio Marra, Antonella Palazzo, et al.
Methods and Protocols|August 28, 2024
Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years of Operation: An Observational Study ProtocolStefano Ferretti, Priscilla Sassoli de Bianchi, Debora Canuti, et al.
Frontiers in Oncology|December 20, 2018
Contribution of <i>MUTYH</i> Variants to Male Breast Cancer Risk: Results From a Multicenter Study in ItalyPiera Rizzolo, Valentina Silvestri, Agostino Bucalo, et al.
International Journal of Molecular Sciences|July 24, 2021
Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory RegionsChiara Guglielmi, Rosa Scarpitta, Gaetana Gambino, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Cancer|September 21, 2016
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility geneValentina Silvestri, Veronica Zelli, Virginia Valentini, et al.
Cancer Treatment Reviews|August 29, 2024
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical reviewAlberto Zambelli, Laura Cortesi, Mariangela Gaudio, et al.
Radiology|January 25, 2007
Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim resultsFrancesco Sardanelli, Franca Podo, Giuliano D'Agnolo, et al.
Pageof 19